Literature DB >> 17397154

Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging.

Jean-Luc Bridot1, Anne-Charlotte Faure, Sophie Laurent, Charlotte Rivière, Claire Billotey, Bassem Hiba, Marc Janier, Véronique Josserand, Jean-Luc Coll, Luce Vander Elst, Robert Muller, Stéphane Roux, Pascal Perriat, Olivier Tillement.   

Abstract

Luminescent hybrid nanoparticles with a paramagnetic Gd2O3 core were applied as contrast agents for both in vivo fluorescence and magnetic resonance imaging. These hybrid particles were obtained by encapsulating Gd2O3 cores within a polysiloxane shell which carries organic fluorophores and carboxylated PEG covalently tethered to the inorganic network. Longitudinal proton relaxivities of these particles are higher than the positive contrast agents like Gd-DOTA which are commonly used for clinical magnetic resonance imaging. Moreover these particles can be followed up by fluorescence imaging. This study revealed that these particles suited for dual modality imaging freely circulate in the blood vessels without undesirable accumulation in lungs and liver.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397154     DOI: 10.1021/ja068356j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  71 in total

Review 1.  Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.

Authors:  Yuejun Fu; Na An; Ke Li; Yali Zheng; Aihua Liang
Journal:  J Neurooncol       Date:  2011-11-23       Impact factor: 4.130

2.  Imaging and quantifying the morphology of an organic-inorganic nanoparticle at the sub-nanometre level.

Authors:  Matti M van Schooneveld; Alexandre Gloter; Odile Stephan; Luiz F Zagonel; Rolf Koole; Andries Meijerink; Willem J M Mulder; Frank M F de Groot
Journal:  Nat Nanotechnol       Date:  2010-06-06       Impact factor: 39.213

3.  Cancer optical imaging using fluorescent nanoparticles.

Authors:  Jean-Luc Coll
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

Review 4.  Inorganic nanoparticle-based contrast agents for molecular imaging.

Authors:  Eun Chul Cho; Charles Glaus; Jingyi Chen; Michael J Welch; Younan Xia
Journal:  Trends Mol Med       Date:  2010-11-10       Impact factor: 11.951

Review 5.  Analytical strategies for detecting nanoparticle-protein interactions.

Authors:  Liwen Li; Qingxin Mu; Bin Zhang; Bing Yan
Journal:  Analyst       Date:  2010-05-26       Impact factor: 4.616

6.  Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Authors:  He Wei; Oliver T Bruns; Michael G Kaul; Eric C Hansen; Mariya Barch; Agata Wiśniowska; Ou Chen; Yue Chen; Nan Li; Satoshi Okada; Jose M Cordero; Markus Heine; Christian T Farrar; Daniel M Montana; Gerhard Adam; Harald Ittrich; Alan Jasanoff; Peter Nielsen; Moungi G Bawendi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

7.  Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma.

Authors:  Zheyu Shen; Ting Liu; Zhen Yang; Zijian Zhou; Wei Tang; Wenpei Fan; Yijing Liu; Jing Mu; Ling Li; Vladimir I Bregadze; Swadhin K Mandal; Anna A Druzina; Zhenni Wei; Xiaozhong Qiu; Aiguo Wu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2020-01-13       Impact factor: 12.479

Review 8.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

9.  Magnetic and optical properties of multifunctional core-shell radioluminescence nanoparticles.

Authors:  Hongyu Chen; Daniel C Colvin; Bin Qi; Thomas Moore; Jian He; O Thompson Mefford; Frank Alexis; John C Gore; Jeffrey N Anker
Journal:  J Mater Chem       Date:  2012-07-07

10.  Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging.

Authors:  Weisheng Guo; Weitao Yang; Yu Wang; Xiaolian Sun; Zhongyun Liu; Bingbo Zhang; Jin Chang; Xiaoyuan Chen
Journal:  Nano Res       Date:  2014-11-01       Impact factor: 8.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.